Yalcin Ipek, Coubard Stéphanie, Bodard Sylvie, Chalon Sylvie, Belzung Catherine
INSERM U-930 FRE CNRS 2448, Faculté des Sciences et Techniques, Université François Rabelais, Parc Grandmont, 37200 Tours, France.
Psychopharmacology (Berl). 2008 Nov;200(4):497-507. doi: 10.1007/s00213-008-1227-3. Epub 2008 Jun 26.
Tramadol is a centrally acting clinically effective analgesic, with a weak opioid receptor affinity. It shows antidepressant-like effects in animal models such as forced swimming test, learned helplessness, and unpredictable chronic mild stress (UCMS) and enhances the concentrations of noradrenaline (NA) and serotonin (5-HT) by interfering with their reuptake and release mechanisms, like some antidepressants.
The aim of this study was to explore whether the antidepressant-like effects of tramadol is affected by the serotonergic system. For this purpose, the effects of a lesion of the dorsal raphe nucleus (DRN) by 5,7-dihydroxytryptamine (5,7-DHT) on the action of tramadol (20 mg/kg, i.p.) on depression-related behavior and neurochemical correlates were investigated in mice. From the third week onward, we administered tramadol chronically during 4 weeks.
Tramadol reversed the physical and behavioral abnormalities induced by the UCMS. Furthermore, the lesion of the DRN by 5,7-DHT antagonized the antidepressant-like effects of tramadol on the coat state, in the splash test but not in the resident-intruder test. The results obtained by high-pressure liquid chromatography showed that the level of 5-HT was reduced by the lesion in some brain regions without affecting the level of NA. Moreover, while the UCMS regimen diminished the level of 5-HT, tramadol increased the level of this neurotransmitter in certain regions.
These results seem to indicate that the serotonergic system is critically involved in the antidepressant-like effects of tramadol in the UCMS in mice.
曲马多是一种中枢性作用的临床有效镇痛药,对阿片受体亲和力较弱。它在强迫游泳试验、习得性无助和不可预测的慢性轻度应激(UCMS)等动物模型中表现出类似抗抑郁的作用,并且像一些抗抑郁药一样,通过干扰去甲肾上腺素(NA)和5-羟色胺(5-HT)的再摄取和释放机制来提高它们的浓度。
本研究旨在探讨曲马多的抗抑郁样作用是否受5-羟色胺能系统影响。为此,研究了用5,7-二羟基色胺(5,7-DHT)损毁背缝核(DRN)对曲马多(20毫克/千克,腹腔注射)作用于小鼠抑郁相关行为和神经化学相关性的影响。从第三周开始,我们在4周内长期给予曲马多。
曲马多逆转了UCMS诱导产生的身体和行为异常。此外,5,7-DHT损毁DRN拮抗了曲马多在皮毛状态、溅水试验中的抗抑郁样作用,但在群居-入侵者试验中未出现这种情况。高压液相色谱法得到的结果表明,损毁某些脑区会降低5-HT水平,但不影响NA水平。此外,虽然UCMS方案降低了5-HT水平,但曲马多可提高某些脑区这种神经递质的水平。
这些结果似乎表明,5-羟色胺能系统在曲马多对小鼠UCMS模型的抗抑郁样作用中起关键作用。